MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,799,926 | -26.9% | 1,628,377 | +4.6% | 0.00% | – |
| Q2 2023 | $10,663,998 | -5.4% | 1,556,788 | +7.6% | 0.00% | – |
| Q1 2023 | $11,275,510 | +3.9% | 1,447,434 | +1.5% | 0.00% | – |
| Q4 2022 | $10,857,294 | -5.6% | 1,426,714 | +1.4% | 0.00% | – |
| Q3 2022 | $11,501,000 | -47.4% | 1,407,667 | -37.8% | 0.00% | -100.0% |
| Q2 2022 | $21,882,000 | -48.0% | 2,262,906 | -24.6% | 0.00% | 0.0% |
| Q1 2022 | $42,098,000 | +90.8% | 3,002,772 | +177.9% | 0.00% | 0.0% |
| Q4 2021 | $22,066,000 | -2.9% | 1,080,616 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $22,726,000 | +901.1% | 1,020,021 | +920.0% | 0.00% | – |
| Q2 2021 | $2,270,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |